chrisvoncsefalvay/vaers-outcomes huggingface dataset:
Fatigue; Trouble breathing; Brain fog; This is a spontaneous report from a contactable consumer (patient). A female patient of an unspecified age received second dose of bnt162b2 (PFIZER-BIONTECH COVID-19 VACCINE, solution for injection, Batch/Lot number was not reported) via an unspecified route of administration on 11Mar2021 as single dose for covid-19 immunization. The patient medical history and concomitant medications were not reported. Historical vaccine included first dose of bnt162b2 (PFIZER-BIONTECH COVID-19 VACCINE, solution for injection, Batch/Lot number was not reported), via an unspecified route of administration on an unspecified date as single dose for covid-19 immunization. On an unspecified date in Mar2021, the patient experienced fatigue, trouble breathing and had brain fog. It was reported that patient received her second dose of Pfizer 11Mar2021. She felt fatigue, trouble breathing with mask and a brain fog. Her doctor ran all kind of test because they saw she was short of breath with the mask. She never had that before. She only had these symptoms after she got the vaccine. It had been 31 or 32 days since she had these symptoms. The patient underwent lab tests and procedures which included blood clot work up, ECG and chest Xray which were found to be normal and had covid test which resulted in negative. The outcome of events was unknown.  No follow-up attempts are needed. No further information is expected.
got the Pfizer vaccination it hurts real bad; hair would come out; This is a spontaneous report from a Pfizer-sponsored program. A non-contactable consumer (patient) reported that a patient of unspecified age and gender received unknown dose number of BNT162B2 (Pfizer Covid Vaccine), via an unspecified route of administration on an unspecified date as single dose for COVID-19 immunisation. Medical history and concomitant medications were not reported. The patient just got the Pfizer vaccination, it hurt real bad. One thing they did not tell the patient about was that his/her hair would come out. The patient stated he/she can't walk around looking like this. Outcome of event was unknown.  No follow-up attempts are possible; information about lot/batch number cannot be obtained.
got the shot next day got shingles; This case was reported by a consumer via media and described the occurrence of shingles in a patient who received Herpes zoster (Shingles vaccine) for prophylaxis.   On an unknown date, the patient received Shingles vaccine. On an unknown date, 1 day after receiving Shingles vaccine, the patient experienced shingles. On an unknown date, the outcome of the shingles was unknown.   It was unknown if the reporter considered the shingles to be related to Shingles vaccine.  Additional details were reported as follows: This case was reported by the patient for herself or himself. The age at vaccination was not reported. The patient got the shingles vaccine and next day got the shingles,not fun.
Chills, fever of 101, nausea, pain at injection site, headache Started around 11pm.  Most intense pain and nausea lasted for around 4 hours.  Was bed ridden until about 2pm the next day. Don't know the manufacturer.  Rx states "Shingrix Vial Kit" and NDC 58160-0823-11
New chicken pox case, 38 year old male. Both children recieved the varicella immunization on May 15, 2007.
Patient complained of being nervous, headache, twitchiness, palpitations, h/o anxiety. Said he ate at 10am. 4:40pm  BP160/100 P99 Pox100% 4:47pm BP 140/90 4:55pm Pox100% P91 BP 140/90  Patient says he feels much better after drinking 8oz water and an 8oz apple juice. Father was present entire time, and he assisted his son with walking out to the car.  Instructions given to follow up with urgent care and/or PCP as needed.
Narrative: this is being documented as a patient was admitted for acute pancreatitis after being fully vaccinated and found to be covid positive. Although the pancreatitis is not thought to be associated with COVID or the vaccine, and we have no evidence of prior infection, we are submitting this report because of the unexcludable possibility that previous or current COVID contributed to this pancreatitis admission.
A week after the shot, my arm from shoulder to elbow had a lot of pain where I can't lift it very well or carry anything without significant pain.
dizziness; headache; fatigue; threw-up; This is a spontaneous report received from a non-contactable reporter(s) (Consumer or other non HCP) from medical information team.  A female patient received bnt162b2 (BNT162B2), administration date 12May2021 (Batch/Lot number: unknown) as dose 2, single for covid-19 immunisation. The patient's relevant medical history and concomitant medications were not reported. Vaccination history included: Bnt162b2 (1st dose), for COVID-19 immunization. The following information was reported: DIZZINESS (non-serious) with onset May2021, outcome "unknown", described as "dizziness"; HEADACHE (non-serious) with onset May2021, outcome "unknown", described as "headache"; FATIGUE (non-serious) with onset May2021, outcome "unknown", described as "fatigue"; VOMITING (non-serious) with onset May2021, outcome "unknown", described as "threw-up".  No follow-up attempts are possible; information about lot/batch number cannot be obtained. No further information is expected.
No adverse event. Child turn 12 1 month. Second vaccine given was pedi Pfizer instead of adult
body ache; Based on the current case data, this case has been classified as invalid. This spontaneous case was reported by a consumer and describes the occurrence of MYALGIA (body ache) in a patient of an unknown age and gender who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.    On an unknown date, the patient received dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On an unknown date, the patient experienced MYALGIA (body ache). At the time of the report, MYALGIA (body ache) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.       no concomitant medication were reported no treatment information was provided    Reporter did not allow further contact
She experienced a raised, red, circular rash with clear borders approximately 2 inches in size at injection site 24 hours after vaccine was administered. She presented herself at our clinic and was evaluated by the provider and instructed to take antihistamines and apply hydrocortisone cream for itching. She complained of a slight headache and itching. No fever noted.
This spontaneous report was received from a medical assistant and refers to a 17 day old patient. The patient's pertinent medical history and concomitant conditions were not provided. On 13-FEB-2016, the patient was vaccinated with the first dose of RECOMBIVAX HB (route, lot number and expiration date were not provided). Then, on 01-MAR-2016, the patient was vaccinated with the second dose of RECOMBIVAX HB (route, lot number and expiration date were not provided) and on 16-MAR-2016, the patient was vaccinated with the third dose of RECOMBIVAX (route, lot number and expiration date were not provided). Concomitant therapy information was not provided. On 01-MAR-2016 and 16-MAR-2016, there was an appropriate schedule of drug administration, as the patient was inadvertently administered the series of RECOMBIVAX HB each dose separated by only two week intervals. It was unknown if the patient sought medical attention. At the time of the report, the patient's status was unknown. Additional information has been requested.
Information has been received from a lawyer regarding a case in litigation concerning a female patient of unknown age. No information was received regarding the patient's past medical history, concurrent conditions, or concomitant medication. The patient was prescribed the ZOSTAVAX by a healthcare provider for the long-term prevention of shingles and zoster-related conditions. In 2014, the patient was administered the ZOSTAVAX by a health care provider (lot number, dosage and route of administration not provided). On an unknown date, the patient was treated by a health care provider for the following injury resulting from her use of ZOSTAVAX: shingles. The patient claims damages as a result of: injury to herself, loss of consortium, loss of services, and economic losses. The outcome of the shingles is unknown. Additional information has been requested.
This spontaneous report was received from a medical assistant referring to multiple patients of unknown demographics. The pertinent medical history, concurrent conditions and concomitant therapies of the patients were not reported. On unknown dates, the patients were vaccinated with improperly stored doses of LIQUID PEDVAXHIB (lot# M034187, expiration date: 17-MAY-2019) (dose, route of administration and anatomical location were not provided), for prophylaxis. The vaccines underwent the temperature excursion of more than 32 Fahrenheit degrees (F) but less than 35 F for 3 hours and 20 minutes, which was detected by a data logger. No previous temperature excursions were reported. No adverse effects were reported. No Product Quality Complaint (PQC) was filed. Follow up information has been received from the medical assistant on 10-MAY-2017, reported that the temperature excursion occurred in the middle of the night when no one was present and the cause was unknown. Follow up information has been received from the medical assistant on 07-JUN-2017. The patients' identifiers, age and gender were provided. The patient was a female infant (reported as Ë 6 months old) patient and was vaccinated with LIQUID PEDVAXHIB in a clinic by a clinic nurse. This is one of several reports from the same reporter. Additional information has been requested.; Sender's Comments: US-009507513-1704USA006513: US-009507513-1704USA010745: US-009507513-1705USA013407: US-009507513-1705USA013406: US-009507513-1705USA013408: US-009507513-1706USA009004: US-009507513-1706USA003615: US-009507513-1706USA009006: US-009507513-1706USA009003: US-009507513-1706USA009001: US-009507513-1706USA009007: US-009507513-1706USA009002:
05/01/2021 - Was at rest - received notification on my watch that my heart rate was spiking, went up to 200 bpm. Felt palpitations and accelerated heart. Went away within an hour after laying down and taking deep breaths.  05/02/2021 - 7-8 PM - Was at rest watching television, got another notification on watch that my heart rate was spiking again, up to 170 bpm. Called Ambulance, where my heart rate was at 140 bp, and was taken to hospital ER. Was evaluated for multiple hours - had EKG, Chest Xray, Chest CT Scan completed showing no blood clots and was released.  05/08/2021 - 9 PM - Was at rest all day, got up to make oatmeal, and had another episode happen, up to 156 bpm. Took prescribed Metropolol and my heart rate came down in about 2 hours.  05/26/2021 - 8 PM - Was preparing to leave for my family members' house, packing bags, and gathering items when I felt the onset of another episode. Was not wearing a watch at this time so my heart rate unknown. Took prescribed atenolol by Cardiologist and palpitations/fast heart rate ended within an hour
Sleepiness; pain at site for >24hrs less than 48hrs; itching on arm below injection site; headache; petichiae on site arm below injection site; sneezing; vivid dreams; swelling in legs; lower appetite; thirsty; more frequently urination with larger amounts; more frequently urination with larger amounts; This is a spontaneous report from a contactable nurse (patient). A 45-year-old female patient (not pregnant) received bnt162b2 (PFIZER-BIONTECH COVID-19 VACCINE, lot/batch number and expiration date not provided), via an unspecified route of administration on 04Jan2021 at 15:45 on arm at single dose for COVID-19 immunization. Medical history included Chronic sinusitis and had known allergies with Gluten and Sulfa. Prior to vaccination, patient was not diagnosed with COVID-19. The patient's concomitant medications reported as none. Patient did not receive any other vaccines within 4 weeks prior to the COVID vaccine. The patient previously took tizanidine hydrochloride (TANIN, reported as tanins) and had known allergy. The patient experienced sleepiness, pain at site for more than 24hours less than 48hours, itching on arm below injection site, headache, petichiae on site arm below injection site, sneezing, vivid dreams, swelling in legs, lower appetite, thirsty, more frequently urination with larger amounts on 04Jan2021 at 19:00. Since the vaccination, patient had not been tested for COVID-19. No treatment was received for the events. The outcome of the events was recovering. The report was reported as non-serious, with seriousness criteria-Results in death: No; Life threatening: No; Caused/prolonged hospitalization: No; Disabling/Incapacitating: No; Congenital anomaly/birth defect: No.  Information on the lot/batch number has been requested.
Dizziness, Myalgia, Arthralgia, Fever, Diarrhea & NauseaVomiting Narrative: GOING TO SEE HIS PCM FOR CONTINUED DIARRHEA
78 YOF with recently diagnosed COVID-19 after tested positive on 10/16, who presented with weakness, general malaise and mental confusion. She was not hypoxic on presentation though had elevated CRP and evidence of ground glass opacities particularly in lower lung field.  She was admitted for observation. During her stay she remained on room air with no change in work of breathing. Her mental status continued to improve. Current suspicious is likely delirium due to acute illness, COVID-19 and ?intake of valume as husband had found his bottles of med at her room and her Utox was also positive for oxazepam. She has been strongly advised to avoid using benzodiazepine without discussing further steps with anxiety management with her PCP.  Upon discharge, patient's CRP has trended down, she is off O2 and reports overall improvement. Given mild- mod presentation for COVID-19, She has completed her 10days of isolation.  She has a hx of chronic DOE  With dilated RV on prior work up and no CAD in 2020 cath. She has been on verapamil and lasix as outpatient. As her PO intake is low and she has no signs of volume overload, her lasix has been on hold while here and she has been instructed to hold while she is unable to eat much. She has been instructed to start if edema or rapid weight gain develops.  She is on verapamil at baseline ( 240mg BID), however BPs have been running low at times while here with occasions of need to hold verapamil. As such she is instructed to take half usual dose for now and check VS at home. Consider advance to usual home dose if BPs are ok.
11/29/21 presents to ED for "shortness of breath and malaise". PMHx of "chronic pancreatitis, DM2, anxiety, and GERD"
Erythema, induration, pain at site of injection to ~ 30 cm x 15 cm at right deltoid PPSV23 3/25/16 PCV 13 given 2/10/16.
I received two immunizations on Dec. 17, 2009: H1N1 Influenza , Varicella. Included is my Kaiser medical record number. Within a few days I showed symptoms of rash and itch. This was confirmed as Herpes Zoster - shingles-.
Burning at injection site and down arm to fingertips immediately felt, lasting couple minutes, eventually went away, months later woke up from sleep with severe pressure above left eye, after 4 hours went away, 2 days later seizure as a result of pressure from intracranial hemorrhage which was the pressure above left eye.   Thrombosis and continued blood pressure issues are ongoing.  Numbness in arms, light headedness, dizziness, headaches, difficulty breathing, confusion, anxiousness, rapid heart rate, irritable to light, chest pains, fuzzy vision and hot flashes.
rt arm where DTAP was given is swollen to greater than fifty cent piece is red, warm tot ouch & feels a knot-instructed mom to apply cool compress & cont giving fever med-mom states pt is not sick or feeling badly
Received flu vaccine in am by dinner time in the evening the area was red, raised and warm. By the morning the area had gotten a little bigger and by Monday morning the area continued to be red, raised and warm. Person went to local Urgent Care they gave her a steroid and told her to come back if it continued to get any bigger. It started to decrease in size that evening.
Fever, body aches, headache, fatigue, painful rash near injection site. Symptoms last 48 hours after injection. Treated with rest and pain reliever.
Vesicular rash in shoulder and trunk (body). Trunk and the shoulder are pustular. Pt states "rash started yesterday (2/22/03)" PT was seen in evening 2/23/03. No other complaints. Afebrile & non-toxic.
felt twitching in face/twitching in arms and legs; jerking movements in my right lower leg; numbness in my hands and feet; nerve irritation moved upward to hips, upper legs and low back,moved into upper back and neck; tingling that started in right thumb, spread to fingers, then into right wrist, right elbow, and up right arm, nerve tingling started in feet; coordination loss currently remain; increasingly weak; stiff in my legs and back; This is a spontaneous report from a contactable consumer (patient). A 37-year-old non-pregnant female patient received BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE), dose 1 via an unspecified route of administration, administered in Right Arm on 10Jul2021 12:45 (Batch/Lot Number: EW0178) as single dose for covid-19 immunisation at the age of 37-year-old. Medical history included allergies. Concomitant medication in two weeks included paracetamol (TYLENOL) taken for an unspecified indication, start and stop date were not reported.  Facility type vaccine: Other. If other vaccine in four weeks: No. The patient previously took tetracycline and wellbutrin and experienced allergies: tetracycline, Wellbutrin. The patient experienced felt twitching in face/twitching in arms and legs on 11Jul2021, tingling that started in right thumb, spread to fingers, then into right wrist, right elbow, and up right arm, nerve tingling started in feet on 10Jul2021 20:30, jerking movements in my right lower leg on 11Jul2021, coordination loss currently remain on Jul2021, numbness in hands and feet on 11Jul2021, nerve irritation moved upward to hips, upper legs and low back,moved into upper back and neck on 11Jul2021, increasingly weak on Jul2021, stiff in legs and back on Jul2021. Clinical course: Approximately 8 hours after receiving the shot on 10Jul2021, the patient had tingling that started in right thumb (the same arm as the vaccine). The tingling spread to fingers, then into right wrist, right elbow, and up right arm. The next day, nerve tingling started in feet. The patient had jerking movements in right lower leg. The patient started twitching in arms and legs and experienced numbness in hands and feet. The nerve irritation moved upward to hips, upper legs, and low back. By Tuesday the patient grew increasingly weak and stiff in legs and back. The patient was also losing coordination. The patient went to the hospital. The next day, the nerve irritation moved into my upper back and neck. The patient felt twitching in my face. Some twitching (arms, legs), numbness (hands, feet), weakness, and coordination loss currently remain. The patient took Aspirin on 22Jul2021 and it caused nerves to flare up again. Currently on 27Jul2021, the patient still have tingling in hands, arms, feet, and legs. If covid prior vaccination: No. If covid tested post vaccination: No. Ae resulted in: Doctor or other healthcare professional office/clinic visit, Emergency room/department or urgent care. Ae treatment: acupuncture. Outcome of all the events was unknown.  Follow-up attempts are completed. No further information is expected.
Information has been received from a nurse practitioner concerning a female patient of unknown age. The patient's concomitant medication, pertinent medical history and drug reactions/allergies were not reported. A year and a half ago, in approximately October 2014, the patient received the first dose of vaccinated with GARDASIL (strength, dose, route, lot # and expiration date not reported) and she received the second dose of GARDASIL (strength, dose, route, lot # and expiration date not reported) on an unspecified date in December 2015 (inappropriate schedule of drug administration). No adverse effect was reported. It was unspecified if the patient sought any medical attention. Additional information has been requested.
Tested positive for COVID 19 on 10/22/2022.  Started Paxlovid afternoon of 10/22/2022. Experience cold and flu like symptoms: sore throat, fatigue, cough, achiness, headache, sneezing, nasal congestion. Symptoms generally resolved after 5 days with  only mild headache and cough remaining. Negative tests on 10/27/2022, 10/28/2022 and 10/29/2022.
This study case was received from the investigator in a trial on 27 November 2013. A male subject (date of birth not reported) with no reported past medical history had received the following vaccinations on 07 November 2013: ACAM2000, typhoid vaccine, anthrax vaccine and FLUMIST (lot numbers, routes and sites not reported) and 13 days later on 20 November 2013 was found to have possible myopericarditis. The subject experienced sudden episodes of shortness of breath beginning on 17 November 2013 and an elevated Troponin I of 0.19 ng/mL on 20 November 2013. Rapid troponin on 20 November 2013 was negative. ECG was normal on 20 November 2013. The subject had no other cardiac symptoms. The subject had no sudden onset of shortness of breath, he was walking up stairs and began having "trouble breathing" that happened multiple times over three days. No treatment was sought and nothing made it better or worse. Shortness of breath ended on 20 November 2013. The subject had no chest pain and marked "no hurt" on the Wong Baker Scale. The subject had a fever of unknown temperature beginning 17 November 2013 and ending on 20 November 2013 that was reported as moderate and treated with Ibuprofen 200mg one time on 19 November 2013. The subject also had mild body aches beginning 17 November 2013 and ending on 20 November 2013. The subject's outcome was still present, no treatment (not recovered). According to the investigator, the event of possible myopericarditis was considered an other important event and was probably related to vaccination. Per the investigator, this represents a case of potential myopericarditis and was referred to the study's adjudication committee for assessment. Documents held by sender: none.
Initial c/o Lightheadedness within 15 min. of vaccine. Episodes of tachycardia 70's - 140's B/P 126/90 Patient monitored & revitaled 1620 B/P 120/72 HR IRREgular 1635 BP 120/72 HR Regular 1645 MD ON SCENE to ASSESS 1655 exited w/husbanD
Initial misuse report received from health care professional on 21 Oct 2013 and at agency on 21 March 2014. It was reported that patient (age and gender not reported) received a dose of FLUZONE on an unspecified date and it was noticed that blood in the syringe. No adverse event was reported. List of documents held by sender: none.
Flu; Initial information was received on 06-Dec-2022 regarding an unsolicited valid  non-serious social media case received from a patient.  This case involves a patient with unknown demographics who got flu after being vaccinated with Influenza vaccine.  The patient's past medical history, medical treatment(s), vaccination(s) and family history were not provided.   On an unknown date, the patient received a dose of suspect Influenza vaccine (produced by unknown manufacturer) (with unknown strength, dose, route, administration site, lot number and expiration date) for prophylactic vaccination.  On an unknown date the patient got flu (influenza) (unknown latency) following the administration of Influenza vaccine.  Action taken: Not applicable.  Corrective treatment: Not reported.  Outcome: Unknown.
Flu vaccine administered through IV instead of IM. No signs or symptoms at the time of administration. 5 hours after administration patient became SOB and had elevated temperature. MD states symptoms not from flu vaccine but from arm infection.